What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Paul Perrotte mostly deals with Surgery, Internal medicine, Urology, Prostate cancer and Renal cell carcinoma.
Paul Perrotte works in the field of Surgery, namely Proportional hazards model.
His Nephrology study in the realm of Internal medicine connects with subjects such as Basic fibroblast growth factor.
His Urology research is multidisciplinary, incorporating elements of Transitional cell carcinoma, Survival rate, Nomogram, Stage and Prostate-specific antigen.
Prostatectomy is the focus of his Prostate cancer research.
Paul Perrotte works mostly in the field of Renal cell carcinoma, limiting it down to concerns involving Nephrectomy and, occasionally, Cohort.
His most cited work include:
- Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. (556 citations)
- Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram (358 citations)
- Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer (327 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Surgery, Internal medicine, Urology, Prostatectomy and Oncology.
His research integrates issues of Logistic regression, Cohort and Carcinoma in his study of Surgery.
His work on Renal cell carcinoma, Nephrology and Epidemiology as part of general Internal medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science.
The study incorporates disciplines such as Nephrectomy and Kidney disease in addition to Renal cell carcinoma.
In his study, Urinary bladder is strongly linked to Cystectomy, which falls under the umbrella field of Urology.
In his study, Radiology is inextricably linked to Lymph node, which falls within the broad field of Prostatectomy.
He most often published in these fields:
- Surgery (45.25%)
- Internal medicine (41.86%)
- Urology (38.01%)
What were the highlights of his more recent work (between 2010-2020)?
- Surgery (45.25%)
- Internal medicine (41.86%)
- Prostatectomy (27.83%)
In recent papers he was focusing on the following fields of study:
Paul Perrotte focuses on Surgery, Internal medicine, Prostatectomy, Renal cell carcinoma and Urology.
His Surgery research includes themes of Logistic regression and Lymph node.
His Internal medicine study frequently links to adjacent areas such as Oncology.
His Prostatectomy study incorporates themes from Nomogram, Complication, General surgery and Charlson comorbidity index.
His studies deal with areas such as Cytoreductive nephrectomy, Nephrectomy, Non metastatic, Carcinoma and Hospital volume as well as Renal cell carcinoma.
The concepts of his Urology study are interwoven with issues in Survival rate, Cumulative incidence, Propensity score matching, Cystectomy and Radiation therapy.
Between 2010 and 2020, his most popular works were:
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysis (262 citations)
- Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis (210 citations)
- Distribution of metastatic sites in patients with prostate cancer: A population-based analysis (156 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
